FASLG and non-small cell lung carcinoma: Using plasma as a proteomic source from patients with NSCLC, the present study implies that MIC-A/B, FASLG, and HGF are all valuable biomarkers and may not only be used as markers for radical removal of NSCLC but also to predict outcomes.